This study indicates that the mROS-TXNIP-NLRP3 pathway is a key signaling cascade in I/R-induced AKI, providing a new avenue for gene therapy targeting the NLRP3 inflammasome signaling pathway (58). This evidence concerns the gene NLRP3 and acute kidney injury.